Fresh2 Group Limited (NASDAQ:FRES – Get Free Report) was the target of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 11,900 shares, an increase of 83.1% from the October 31st total of 6,500 shares. Based on an average daily trading volume, of 44,400 shares, the short-interest ratio is currently 0.3 days.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group upgraded Fresh2 Group to a “strong-buy” rating in a research report on Thursday, August 8th.
Get Our Latest Analysis on FRES
Fresh2 Group Price Performance
Fresh2 Group Company Profile
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc.
Featured Articles
- Five stocks we like better than Fresh2 Group
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Profitably Trade Stocks at 52-Week Highs
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Fresh2 Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh2 Group and related companies with MarketBeat.com's FREE daily email newsletter.